annual CFI:
-$553.10M-$792.35M(-331.18%)Summary
- As of today (June 28, 2025), CYTK annual cash flow from investing activities is -$553.10 million, with the most recent change of -$792.35 million (-331.18%) on December 31, 2024.
- During the last 3 years, CYTK annual CFI has fallen by -$405.32 million (-274.28%).
- CYTK annual CFI is now -331.18% below its all-time high of $239.25 million, reached on December 31, 2023.
Performance
CYTK Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$105.96M-$4.91M(-4.43%)Summary
- As of today (June 28, 2025), CYTK quarterly cash flow from investing activities is $105.96 million, with the most recent change of -$4.91 million (-4.43%) on March 1, 2025.
- Over the past year, CYTK quarterly CFI has increased by +$73.31 million (+224.61%).
- CYTK quarterly CFI is now -35.98% below its all-time high of $165.50 million, reached on March 31, 2023.
Performance
CYTK quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$479.78M+$73.31M(+13.26%)Summary
- As of today (June 28, 2025), CYTK TTM cash flow from investing activities is -$479.78 million, with the most recent change of +$73.31 million (+13.26%) on March 1, 2025.
- Over the past year, CYTK TTM CFI has dropped by -$586.18 million (-550.94%).
- CYTK TTM CFI is now -237.11% below its all-time high of $349.91 million, reached on September 30, 2023.
Performance
CYTK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CYTK Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -331.2% | +224.6% | -550.9% |
| 3 y3 years | -274.3% | +264.8% | -132.0% |
| 5 y5 years | -640.4% | +143.6% | -843.3% |
CYTK Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -331.2% | at low | -36.0% | +116.3% | -237.1% | +35.6% |
| 5 y | 5-year | -331.2% | at low | -36.0% | +116.3% | -237.1% | +35.6% |
| alltime | all time | -331.2% | at low | -36.0% | +116.3% | -237.1% | +35.6% |
CYTK Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $105.96M(-4.4%) | -$479.78M(-13.3%) |
| Dec 2024 | -$553.10M(-331.2%) | $110.86M(-346.1%) | -$553.10M(-25.8%) |
| Sep 2024 | - | -$45.05M(-93.1%) | -$745.37M(+18.8%) |
| Jun 2024 | - | -$651.55M(-2096.1%) | -$627.28M(-689.6%) |
| Mar 2024 | - | $32.64M(-140.1%) | $106.40M(-55.5%) |
| Dec 2023 | $239.25M(-191.3%) | -$81.41M(-211.5%) | $239.25M(-31.6%) |
| Sep 2023 | - | $73.04M(-11.1%) | $349.91M(-2357.8%) |
| Jun 2023 | - | $82.13M(-50.4%) | -$15.50M(-52.1%) |
| Mar 2023 | - | $165.50M(+465.8%) | -$32.36M(-87.7%) |
| Dec 2022 | -$262.13M(+77.4%) | $29.25M(-110.0%) | -$262.13M(+7.4%) |
| Sep 2022 | - | -$292.37M(-548.0%) | -$244.05M(+52.2%) |
| Jun 2022 | - | $65.27M(-201.5%) | -$160.39M(-22.4%) |
| Mar 2022 | - | -$64.28M(-235.8%) | -$206.78M(+39.9%) |
| Dec 2021 | -$147.78M(-24.8%) | $47.34M(-122.7%) | -$147.78M(-59.9%) |
| Sep 2021 | - | -$208.72M(-1205.4%) | -$368.73M(+41.3%) |
| Jun 2021 | - | $18.88M(-457.9%) | -$261.04M(+6.4%) |
| Mar 2021 | - | -$5.28M(-97.0%) | -$245.28M(+24.8%) |
| Dec 2020 | -$196.51M(+163.0%) | -$173.62M(+71.9%) | -$196.51M(+53.3%) |
| Sep 2020 | - | -$101.02M(-391.7%) | -$128.16M(+852.3%) |
| Jun 2020 | - | $34.64M(-20.4%) | -$13.46M(-73.5%) |
| Mar 2020 | - | $43.49M(-141.3%) | -$50.86M(-31.9%) |
| Dec 2019 | -$74.71M(-1555.4%) | -$105.27M(-869.4%) | -$74.71M(-230.9%) |
| Sep 2019 | - | $13.68M(-594.5%) | $57.07M(+23.9%) |
| Jun 2019 | - | -$2.77M(-114.1%) | $46.06M(+892.5%) |
| Mar 2019 | - | $19.64M(-25.9%) | $4.64M(-9.6%) |
| Dec 2018 | $5.13M(-107.8%) | $26.51M(+890.2%) | $5.13M(-45.3%) |
| Sep 2018 | - | $2.68M(-106.1%) | $9.39M(-79.8%) |
| Jun 2018 | - | -$44.19M(-319.4%) | $46.37M(-30.4%) |
| Mar 2018 | - | $20.14M(-34.5%) | $66.61M(-201.2%) |
| Dec 2017 | -$65.83M(+26.4%) | $30.76M(-22.4%) | -$65.83M(-52.5%) |
| Sep 2017 | - | $39.66M(-265.6%) | -$138.56M(-15.6%) |
| Jun 2017 | - | -$23.95M(-78.7%) | -$164.25M(+13.9%) |
| Mar 2017 | - | -$112.30M(+167.6%) | -$144.22M(+176.9%) |
| Dec 2016 | -$52.08M(-424.2%) | -$41.97M(-400.4%) | -$52.08M(-440.3%) |
| Sep 2016 | - | $13.97M(-456.8%) | $15.30M(+21.1%) |
| Jun 2016 | - | -$3.92M(-80.6%) | $12.64M(-54.8%) |
| Mar 2016 | - | -$20.16M(-179.3%) | $28.00M(+74.3%) |
| Dec 2015 | $16.06M(-496.7%) | $25.41M(+124.8%) | $16.06M(-627.7%) |
| Sep 2015 | - | $11.31M(-1.2%) | -$3.04M(-28.9%) |
| Jun 2015 | - | $11.44M(-135.6%) | -$4.28M(-41.2%) |
| Mar 2015 | - | -$32.09M(-609.1%) | -$7.28M(+79.8%) |
| Dec 2014 | -$4.05M | $6.30M(-37.4%) | -$4.05M(-10.8%) |
| Sep 2014 | - | $10.07M(+19.3%) | -$4.54M(-79.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $8.44M(-129.2%) | -$22.20M(-45.7%) |
| Mar 2014 | - | -$28.86M(-596.5%) | -$40.85M(+2589.2%) |
| Dec 2013 | -$1.52M(-94.7%) | $5.81M(-176.6%) | -$1.52M(+112.2%) |
| Sep 2013 | - | -$7.59M(-25.6%) | -$716.00K(-97.8%) |
| Jun 2013 | - | -$10.21M(-197.5%) | -$32.10M(+37.2%) |
| Mar 2013 | - | $10.47M(+58.3%) | -$23.40M(-18.8%) |
| Dec 2012 | -$28.82M(-213.9%) | $6.62M(-117.0%) | -$28.82M(+8.2%) |
| Sep 2012 | - | -$38.97M(+2482.8%) | -$26.64M(-260.5%) |
| Jun 2012 | - | -$1.51M(-129.9%) | $16.60M(-13.9%) |
| Mar 2012 | - | $5.05M(-42.5%) | $19.28M(-23.8%) |
| Dec 2011 | $25.30M(-26.1%) | $8.79M(+106.2%) | $25.30M(+221.9%) |
| Sep 2011 | - | $4.26M(+263.9%) | $7.86M(-70.2%) |
| Jun 2011 | - | $1.17M(-89.4%) | $26.36M(-35.1%) |
| Mar 2011 | - | $11.07M(-228.0%) | $40.60M(+18.6%) |
| Dec 2010 | $34.24M(-164.0%) | -$8.65M(-138.0%) | $34.24M(-33.3%) |
| Sep 2010 | - | $22.76M(+47.6%) | $51.36M(-369.5%) |
| Jun 2010 | - | $15.42M(+227.8%) | -$19.05M(-60.7%) |
| Mar 2010 | - | $4.70M(-44.5%) | -$48.53M(-9.3%) |
| Dec 2009 | -$53.48M(+436.6%) | $8.47M(-117.8%) | -$53.48M(-30.5%) |
| Sep 2009 | - | -$47.65M(+239.0%) | -$77.00M(+175.0%) |
| Jun 2009 | - | -$14.05M(+5544.2%) | -$28.00M(+99.6%) |
| Mar 2009 | - | -$249.00K(-98.3%) | -$14.03M(+40.7%) |
| Dec 2008 | -$9.97M(-121.9%) | -$15.05M(-1210.0%) | -$9.97M(-138.4%) |
| Sep 2008 | - | $1.36M(-1733.7%) | $25.95M(+2.9%) |
| Jun 2008 | - | -$83.00K(-102.2%) | $25.21M(-45.6%) |
| Mar 2008 | - | $3.81M(-81.7%) | $46.34M(+1.9%) |
| Dec 2007 | $45.46M(-432.3%) | $20.87M(+3292.8%) | $45.46M(-701.0%) |
| Sep 2007 | - | $615.00K(-97.1%) | -$7.57M(+40.6%) |
| Jun 2007 | - | $21.05M(+618.2%) | -$5.38M(-88.0%) |
| Mar 2007 | - | $2.93M(-109.1%) | -$45.01M(+229.0%) |
| Dec 2006 | -$13.68M(-139.7%) | -$32.16M(-1248.6%) | -$13.68M(-156.1%) |
| Sep 2006 | - | $2.80M(-115.1%) | $24.40M(-21.2%) |
| Jun 2006 | - | -$18.58M(-154.2%) | $30.98M(-46.5%) |
| Mar 2006 | - | $34.26M(+478.5%) | $57.89M(+67.8%) |
| Dec 2005 | $34.49M(-152.7%) | $5.92M(-36.8%) | $34.49M(+7.1%) |
| Sep 2005 | - | $9.38M(+12.6%) | $32.20M(-6.0%) |
| Jun 2005 | - | $8.33M(-23.3%) | $34.24M(-157.2%) |
| Mar 2005 | - | $10.86M(+199.1%) | -$59.86M(-8.6%) |
| Dec 2004 | -$65.51M(+333.2%) | $3.63M(-68.2%) | -$65.51M(-5.3%) |
| Sep 2004 | - | $11.42M(-113.3%) | -$69.14M(-14.2%) |
| Jun 2004 | - | -$85.77M(-1744.1%) | -$80.56M(-1644.1%) |
| Mar 2004 | - | $5.22M | $5.22M |
| Dec 2003 | -$15.12M(-167.0%) | - | - |
| Dec 2002 | $22.58M | - | - |
FAQ
- What is Cytokinetics Incorporated annual cash flow from investing activities?
- What is the all time high annual CFI for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CFI year-on-year change?
- What is Cytokinetics Incorporated quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly CFI year-on-year change?
- What is Cytokinetics Incorporated TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM CFI year-on-year change?
What is Cytokinetics Incorporated annual cash flow from investing activities?
The current annual CFI of CYTK is -$553.10M
What is the all time high annual CFI for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual cash flow from investing activities is $239.25M
What is Cytokinetics Incorporated annual CFI year-on-year change?
Over the past year, CYTK annual cash flow from investing activities has changed by -$792.35M (-331.18%)
What is Cytokinetics Incorporated quarterly cash flow from investing activities?
The current quarterly CFI of CYTK is $105.96M
What is the all time high quarterly CFI for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly cash flow from investing activities is $165.50M
What is Cytokinetics Incorporated quarterly CFI year-on-year change?
Over the past year, CYTK quarterly cash flow from investing activities has changed by +$73.31M (+224.61%)
What is Cytokinetics Incorporated TTM cash flow from investing activities?
The current TTM CFI of CYTK is -$479.78M
What is the all time high TTM CFI for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM cash flow from investing activities is $349.91M
What is Cytokinetics Incorporated TTM CFI year-on-year change?
Over the past year, CYTK TTM cash flow from investing activities has changed by -$586.18M (-550.94%)